Company News, Financial News

Bridgepoint Capital To Acquire RoC Skincare

Gryphon Investors agrees to sell its share of the dermatologist-inspired beauty brand.

RoC Skincare, the French dermatological brand, will be acquired by Bridgepoint Capital. Terms of the acquisition were not disclosed. The deal is expected to be completed next month. Gryphon Investors, RoC’s biggest investor, will sell its majority stake to Bridgeport at part of the acquisition.

The deal will go through Bridgepoint Europe VII, Bridgepoint’s fund centered on investing in mid-market growth businesses.

“The dermocosmetic facial skincare market in the US and Europe is set to continue to grow ahead of the broader skin care space, a trend mirrored in products for aging skin,” Bridgepoint said in a statement. 

Gryphon Investors, San Francisco, acquired RoC Skincare from Johnson & Johnson in 2019. J&J spun-off its consumer products business in 2022. Kenvue owns such well-known brands as Johnson's, Aveeno and Listerine.


Related Content:


RoC Skincare Collaborates with Dermatologists for Restorative Skin Barrier Collection

Gryphon Investors Acquires Revison Goodier

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters